304 related articles for article (PubMed ID: 15062998)
1. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin.
van der Kraan MI; Groenink J; Nazmi K; Veerman EC; Bolscher JG; Nieuw Amerongen AV
Peptides; 2004 Feb; 25(2):177-83. PubMed ID: 15062998
[TBL] [Abstract][Full Text] [Related]
2. Novel lactoferrampin antimicrobial peptides derived from human lactoferrin.
Haney EF; Nazmi K; Lau F; Bolscher JG; Vogel HJ
Biochimie; 2009 Jan; 91(1):141-54. PubMed ID: 18534196
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix-facilitating N-terminal part.
van der Kraan MI; Nazmi K; Teeken A; Groenink J; van 't Hof W; Veerman EC; Bolscher JG; Nieuw Amerongen AV
Biol Chem; 2005 Feb; 386(2):137-42. PubMed ID: 15843157
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides.
Bolscher JG; Adão R; Nazmi K; van den Keybus PA; van 't Hof W; Nieuw Amerongen AV; Bastos M; Veerman EC
Biochimie; 2009 Jan; 91(1):123-32. PubMed ID: 18573310
[TBL] [Abstract][Full Text] [Related]
5. Influence of specific amino acid side-chains on the antimicrobial activity and structure of bovine lactoferrampin.
Haney EF; Nazmi K; Bolscher JG; Vogel HJ
Biochem Cell Biol; 2012 Jun; 90(3):362-77. PubMed ID: 22250712
[TBL] [Abstract][Full Text] [Related]
6. A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin.
Bolscher JG; van der Kraan MI; Nazmi K; Kalay H; Grün CH; Van't Hof W; Veerman EC; Nieuw Amerongen AV
Peptides; 2006 Jan; 27(1):1-9. PubMed ID: 16087276
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification, and antibacterial activity of bovine lactoferrampin-lactoferricin in Pichia pastoris.
Tang XS; Tang ZR; Wang SP; Feng ZM; Zhou D; Li TJ; Yin YL
Appl Biochem Biotechnol; 2012 Feb; 166(3):640-51. PubMed ID: 22109740
[TBL] [Abstract][Full Text] [Related]
8. Design and activity of novel lactoferrampin analogues against O157:H7 enterohemorrhagic Escherichia coli.
Cruz J; Ortiz C; Guzmán F; Cárdenas C; Fernandez-Lafuente R; Torres R
Biopolymers; 2014 Apr; 101(4):319-28. PubMed ID: 23877962
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.
Kimura M; Nam MS; Ohkouchi Y; Kumura H; Shimazaki Ki; Yu DY
Biochem Biophys Res Commun; 2000 Feb; 268(2):333-6. PubMed ID: 10679204
[TBL] [Abstract][Full Text] [Related]
10. Recent studies on the antimicrobial peptides lactoferricin and lactoferrampin.
Yin C; Wong JH; Ng TB
Curr Mol Med; 2014; 14(9):1139-54. PubMed ID: 25324002
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli.
van der Kraan MI; van Marle J; Nazmi K; Groenink J; van 't Hof W; Veerman EC; Bolscher JG; Nieuw Amerongen AV
Peptides; 2005 Sep; 26(9):1537-42. PubMed ID: 16112390
[TBL] [Abstract][Full Text] [Related]
12. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
[TBL] [Abstract][Full Text] [Related]
13. Chimerization of lactoferricin and lactoferrampin peptides strongly potentiates the killing activity against Candida albicans.
Bolscher J; Nazmi K; van Marle J; van 't Hof W; Veerman E
Biochem Cell Biol; 2012 Jun; 90(3):378-88. PubMed ID: 22364313
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin.
Hwang PM; Zhou N; Shan X; Arrowsmith CH; Vogel HJ
Biochemistry; 1998 Mar; 37(12):4288-98. PubMed ID: 9521752
[TBL] [Abstract][Full Text] [Related]
15. Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference.
van der Kraan MI; Nazmi K; van 't Hof W; Amerongen AV; Veerman EC; Bolscher JG
Biochem Cell Biol; 2006 Jun; 84(3):358-62. PubMed ID: 16936807
[TBL] [Abstract][Full Text] [Related]
16. Anti herpes simplex virus activity of lactoferrin/lactoferricin -- an example of antiviral activity of antimicrobial protein/peptide.
Jenssen H
Cell Mol Life Sci; 2005 Dec; 62(24):3002-13. PubMed ID: 16261265
[TBL] [Abstract][Full Text] [Related]
17. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
Farnaud S; Patel A; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
[TBL] [Abstract][Full Text] [Related]
18. Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin.
Silva T; Abengózar MÁ; Fernández-Reyes M; Andreu D; Nazmi K; Bolscher JG; Bastos M; Rivas L
Amino Acids; 2012 Dec; 43(6):2265-77. PubMed ID: 22543751
[TBL] [Abstract][Full Text] [Related]
19. Anti-complement effects of lactoferrin-derived peptides.
Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of acylation and amidation on the antimicrobial and antiviral properties of lactoferrin.
Pan Y; Wan J; Roginski H; Lee A; Shiell B; Michalski WP; Coventry MJ
Lett Appl Microbiol; 2007 Mar; 44(3):229-34. PubMed ID: 17309497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
